Comparison of Cardiovascular Events in Patients Receiving Concomitant Clopidogrel and Proton Pump Inhibitors Classified by CYP2C19 Inhibitory Potency.

Kim S, Park J, Chen HY, Setiawan CH, Lee H, Martin B, Lee KJ, Hripcsak G, Hsu JC, Nagy P, Kim S, Nguyen PA, Thanh-Phuc P, Muhtar MS, Hsu MH, Shin WG, You SC, Seo SI

Open source

DOI
10.1161/atvbaha.125.323399
Published
2026 May
Container
Arteriosclerosis, thrombosis, and vascular biology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1161/atvbaha.125.323399,
  title = {Comparison of Cardiovascular Events in Patients Receiving Concomitant Clopidogrel and Proton Pump Inhibitors Classified by CYP2C19 Inhibitory Potency.},
  author = {Kim S and Park J and Chen HY and Setiawan CH and Lee H and Martin B and Lee KJ and Hripcsak G and Hsu JC and Nagy P and Kim S and Nguyen PA and Thanh-Phuc P and Muhtar MS and Hsu MH and Shin WG and You SC and Seo SI},
  year = {2026},
  journal = {Arteriosclerosis, thrombosis, and vascular biology},
  doi = {10.1161/atvbaha.125.323399},
  url = {https://doi.org/10.1161/atvbaha.125.323399}
}

RIS

TY  - JOUR
TI  - Comparison of Cardiovascular Events in Patients Receiving Concomitant Clopidogrel and Proton Pump Inhibitors Classified by CYP2C19 Inhibitory Potency.
AU  - Kim S
AU  - Park J
AU  - Chen HY
AU  - Setiawan CH
AU  - Lee H
AU  - Martin B
AU  - Lee KJ
AU  - Hripcsak G
AU  - Hsu JC
AU  - Nagy P
AU  - Kim S
AU  - Nguyen PA
AU  - Thanh-Phuc P
AU  - Muhtar MS
AU  - Hsu MH
AU  - Shin WG
AU  - You SC
AU  - Seo SI
PY  - 2026
JO  - Arteriosclerosis, thrombosis, and vascular biology
DO  - 10.1161/atvbaha.125.323399
UR  - https://doi.org/10.1161/atvbaha.125.323399
ER  - 

APA

S, K., J, P., HY, C., CH, S., H, L., B, M., KJ, L., G, H., JC, H., P, N., S, K., PA, N., P, T., MS, M., MH, H., WG, S., SC, Y., & SI, S. (2026). Comparison of Cardiovascular Events in Patients Receiving Concomitant Clopidogrel and Proton Pump Inhibitors Classified by CYP2C19 Inhibitory Potency.. Arteriosclerosis, thrombosis, and vascular biology. https://doi.org/10.1161/atvbaha.125.323399

Source records